4//SEC Filing
Deschamps Philippe 4
Accession 0001683168-23-000428
CIK 0001759186other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 10:53 AM ET
Size
6.0 KB
Accession
0001683168-23-000428
Insider Transaction Report
Form 4
Deschamps Philippe
Director
Transactions
- Award
Non-qualified Stock Options (right to buy)
2023-01-27+30,000→ 30,000 totalExercise: $1.60→ Common Stock (30,000 underlying)
Footnotes (4)
- [F1]On January 27, 2023, the reporting person received a grant of 30,000 stock options, as non-qualified options, under the 2022 equity incentive plan.
- [F2]The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant.
- [F3]Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2023, the next 25% vesting on 6/30/2023, the next 25% vesting on 9/30/23, and the final 25% vesting on 12/31/23.
- [F4]Expiration date is ten years from the day of grant.
Documents
Issuer
Coeptis Therapeutics Holdings, Inc.
CIK 0001759186
Entity typeother
Related Parties
1- filerCIK 0001638231
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 10:53 AM ET
- Size
- 6.0 KB